Howard Hughes Investigator and Thomas and Stacey Siebel Distinguished Chair in Stem Cell Biology and Professor of Genetics, Genomics and Development Andrew Dillin, together with Nobelist Stan Prusiner from UCSF, will lead a new integrated center for research on neurodegenerative diseases. The center will be funded by $3 million from the Glenn Foundation for Medical Research and will pave the way for novel treatments for diseases linked to misfolded proteins and/or prions.